Damora Therapeutics, Inc. (DMRA) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of Damora Therapeutics, Inc. and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$19.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$11.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DMRA vs ORIC
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)ORIC -39.1% (-7.9%/yr)ORIC compounded faster over this window
Log scale — wide-divergence pair
DMRA ORIC
DMRA vs ORIC: by the numbers
- •ORIC is the larger company ($1.24B vs $1.20B market cap).
Metrics side by side
Valuation
| Metric | DMRA | ORIC |
|---|---|---|
| P/B ratio | 3.12 | 3.25 |
Profitability
| Metric | DMRA | ORIC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -50.93% | -36.81% |
| ROIC | -52.44% | -40.32% |
Growth (annualized)
| Metric | DMRA | ORIC |
|---|---|---|
| Total return CAGR (5Y) | -25.05% | -8.73% |
Frequently asked
- How have DMRA and ORIC total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and ORIC delivered -8.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.